Mario A. Pisarev

1917 Rivadavia St
Ministro Rivadavia, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC).

Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC).

Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine

Published: April 01, 2019

Participation of NADPH 4 oxidase in thyroid regulation.

Participation of NADPH 4 oxidase in thyroid regulation.

Journal: Molecular and cellular endocrinology

Published: June 29, 2018

Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid.

Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid.

Journal: Molecular and cellular endocrinology

Published: May 11, 2018

Comparative effects of transforming growth factor beta isoforms on redox metabolism in thyroid cells.

Comparative effects of transforming growth factor beta isoforms on redox metabolism in thyroid cells.

Journal: Molecular and cellular endocrinology

Published: August 15, 2017

Regulation of NADPH oxidase NOX4 by delta iodolactone (IL-δ) in thyroid cancer cells.

Regulation of NADPH oxidase NOX4 by delta iodolactone (IL-δ) in thyroid cancer cells.

Journal: Molecular and cellular endocrinology

Published: August 09, 2017

In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line.

In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line.

Journal: Radiation and environmental biophysics

Published: February 10, 2017

Effects of 2-iodohexadecanal in the physiology of thyroid cells.

Effects of 2-iodohexadecanal in the physiology of thyroid cells.

Journal: Molecular and cellular endocrinology

Published: June 10, 2016

2-Iodohexadecanal inhibits thyroid cell growth in part through the induction of let-7f microRNA.

2-Iodohexadecanal inhibits thyroid cell growth in part through the induction of let-7f microRNA.

Journal: Molecular and cellular endocrinology

Published: June 18, 2015

Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.

Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.

Journal: International journal of radiation oncology, biology, physics

Published: February 12, 2015

Inhibitory effects of 2-iodohexadecanal on FRTL-5 thyroid cells proliferation.

Inhibitory effects of 2-iodohexadecanal on FRTL-5 thyroid cells proliferation.

Journal: Molecular and cellular endocrinology

Published: October 31, 2014

Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines.

Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines.

Journal: International journal of radiation biology

Published: July 10, 2014

Protective effect of an antithyroid compound against γ-radiation-induced damage in human colon cancer cells.

Protective effect of an antithyroid compound against γ-radiation-induced damage in human colon cancer cells.

Journal: Radiation and environmental biophysics

Published: October 03, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026